Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel
NASDAQ:CRVO

CervoMed Q1 2026 Earnings Report

CervoMed logo
$3.10 -0.05 (-1.59%)
Closing price 04:00 PM Eastern
Extended Trading
$3.15 +0.05 (+1.61%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

CervoMed EPS Results

Actual EPS
-$0.86
Consensus EPS
-$0.90
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

CervoMed Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.07 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

CervoMed Announcement Details

Quarter
Q1 2026
Date
5/15/2026
Time
Before Market Opens
Conference Call Date
Friday, May 15, 2026
Conference Call Time
7:00AM ET

Upcoming Earnings

CervoMed's Q2 2026 earnings is estimated for Friday, August 14, 2026, based on past reporting schedules, with a conference call scheduled on Friday, August 7, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Powered by Quartr

Earnings Documents

CervoMed's Q1 2026 Press ReleasePress Release
(8-K)
CervoMed's Q1 2026 Quarterly reportQuarterly report
(10-Q)

CervoMed Earnings Headlines

CervoMed Inc. (NASDAQ:CRVO) Receives Consensus Rating of "Moderate Buy" from Analysts
June 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30860839
CervoMed Raises $10 Million in Direct Offering
June 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/cervomed-raises-10-million-in-direct-offering?utm_source=marketbeat.com&utm_medium=referral
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel
June 30 at 1:00 AM  |  Porter & Company (Ad)
CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
June 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/22/3315604/0/en/cervomed-announces-closing-of-10-million-registered-direct-offering-of-common-stock-priced-at-the-market-under-nasdaq-rules.html
Penny Stocks To Add to Your Watchlist - June 21st
June 22, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30854763
Top Penny Stocks To Research - June 20th
June 21, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30852638
See More CervoMed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CervoMed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CervoMed and other key companies, straight to your email.

About CervoMed

CervoMed (NASDAQ:CRVO), a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

View CervoMed Profile
Earnings Tools